Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium bolus versus continuous infusion during thoracolaparoscopic esophagectomy
NL-OMON40986Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of rocuronium and Sugammadex, sponsored by Amsterdam University Medical Center. Started Feb 2015; status: active, not recruiting.
02
Drugs
rocuroniumSugammadex
Beyond the preview
Go deeper on NL-OMON40986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40986.